Pfizer Halts Research Efforts Into Alzheimer's And Parkinson's Treatments
The pharmaceutical giant said it would be abandoning its neuroscience development programs and allocating its spending elsewhere. The move also means the company will be laying off some 300 employees.
Read more on NPR
No comments:
Post a Comment